Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

DOI Full Paper Access

22

Citations

35

References

2022

Year

Elisabeth De Leeuw, Karel Van Damme, Jozefien Declercq, Cédric Bosteels, Bastiaan Maes, Simon J. Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf,

Respiratory Research

References

	Year	Citations

Page 1